Organic compounds -- part of the class 532-570 series – Organic compounds – Heterocyclic carbon compounds containing a hetero ring...
Reexamination Certificate
2008-04-21
2011-10-18
Stockton, Laura L. (Department: 1626)
Organic compounds -- part of the class 532-570 series
Organic compounds
Heterocyclic carbon compounds containing a hetero ring...
C514S365000
Reexamination Certificate
active
08039635
ABSTRACT:
N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)phenoxy]pentoxy} benzamidine 2 ethansulfonic acid salt, a process for the preparation thereof, a pharmaceutical composition for preventing and treating osteoporosis, bone fractures or allergic inflammatory diseases, comprising the same, and an oral formulation for preventing and treating osteoporosis, bone fractures or allergic inflammatory diseases, comprising the same are described.
REFERENCES:
patent: WO 03-007947 (2003-01-01), None
patent: WO 2006-004369 (2006-01-01), None
patent: WO 2006-004370 (2006-01-01), None
patent: WO 2006-057501 (2006-06-01), None
patent: WO 2006-057507 (2006-06-01), None
Cha Ja Hyun
Cho Eun Hee
Cho Soon Ki
Jin Young Goo
Kim Bo Kyung
Arent & Fox LLP
Dong Wha Pharmaceutical Co., Ltd.
Stockton Laura L.
LandOfFree
N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and N-hydroxy-4-{5-[4-(5-isopropyl-2-methyl-1,3-thiazol-4-yl)... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4275625